Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer
Ulrike Nitz, Eva‐Maria Grischke, Oleg Gluz, Matthias Christgen et al.
Citations
5 citations
Journal
JAMA Network Open
Topics
Breast Cancer Treatment Studies
Field-Weighted Citation Impact (FWCI)
4.68
article
Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer
Ulrike Nitz, Eva‐Maria Grischke, Oleg Gluz, Matthias Christgen, Ronald Kates, Nadia Harbeck, Rachel Wuerstlein, Monika Graeser, Janine Altmüller, Mohamad Kayali, Hans Heinrich Kreipe, Michael Braun, Sherko Küemmel, Nana Weber‐Lassalle, Sabine C. Linn, Jan Hauke, Eric Hahnen, Holger Thiele, Helmut Forstbauer, Corinna Ernst, Lisa Richters, Mathias Warm, Heinz Haverkamp, Rita K. Schmutzler, Anna Ossowski
article en
5 citations
Abstract
No abstract available for this paper.
Publication Tag
JAMA Network OpenVol. 8(2)
Institutions
Miltenyi Biotec (Germany) (DE), Universität Hamburg (DE), University of Cologne (DE), Max Delbrück Center (DE), Deutsches Archäologisches Institut, Zentrale (DE), The Netherlands Cancer Institute (NL), University Medical Center Utrecht (NL), Medizinische Hochschule Hannover (DE), University Medical Center Hamburg-Eppendorf (DE), Oncode Institute (NL), University Children's Hospital Tübingen (DE), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), Kliniken Essen-Mitte (DE), Rotkreuzklinikum München (DE), University Hospital Cologne (DE), Atos Medical (DE), Krankenhaus Köln-Holweide (DE), Charité - Universitätsmedizin Berlin (DE), Ludwig-Maximilians-Universität München (DE)
Funders
Teva Pharmaceutical Industries, Celgene, Universität zu Köln, Universitätsklinikum Köln, Berlin Institute of Health